Medix Biochemica announces $5 million investment to expand recombinant antigen capabilities
May 18, 2026
May 18, 2026
May 7, 2026
October 6, 2025
September 30, 2025
December 10, 2024
October 28, 2024
October 8, 2024
August 13, 2024
June 11, 2024
May 19, 2026
Engineered with the "Integrated Safety" concept and 100% tested via the automated RoboMAG production line, IKA’s new stirrers set a new global standar...
May 19, 2026
Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure...
May 18, 2026
Medix Biochemica’s Board approved a $5 million investment to expand recombinant and cell culture antigen capabilities at its Espoo, Finland and St. Lo...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225